Prescribing More Stringent Design of Randomized Clinical Trials of Omega-3 Polyunsaturated Fatty Acids

Affiliations

Comment

Peter L McLennan et al. Mayo Clin Proc. 2017 Jun.

. 2017 Jun;92(6):1005-1006.

doi: 10.1016/j.mayocp.2017.03.019.

No abstract available

Comment in

In Reply I-Prescribing More Stringent Design of Randomized Clinical Trials of Omega-3 Polyunsaturated Fatty Acids.
Alexander DD. Alexander DD. Mayo Clin Proc. 2017 Jun;92(6):1006-1007. doi: 10.1016/j.mayocp.2017.04.003. Mayo Clin Proc. 2017. PMID: 28578777 No abstract available.
In Reply II-Prescribing More Stringent Design of Randomized Clinical Trials of Omega-3 Polyunsaturated Fatty Acids.
O'Keefe JH, Lavie CJ. O'Keefe JH, et al. Mayo Clin Proc. 2017 Jun;92(6):1007-1008. doi: 10.1016/j.mayocp.2017.03.018. Mayo Clin Proc. 2017. PMID: 28578778 No abstract available.

Omega-3 Fatty Acid Therapy: The Tide Turns for a Fish Story.
O'Keefe JH, Jacob D, Lavie CJ. O'Keefe JH, et al. Mayo Clin Proc. 2017 Jan;92(1):1-3. doi: 10.1016/j.mayocp.2016.11.008. Mayo Clin Proc. 2017. PMID: 28062059 No abstract available.
A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk.
Alexander DD, Miller PE, Van Elswyk ME, Kuratko CN, Bylsma LC. Alexander DD, et al. Mayo Clin Proc. 2017 Jan;92(1):15-29. doi: 10.1016/j.mayocp.2016.10.018. Mayo Clin Proc. 2017. PMID: 28062061 Review.